This statistic shows the expenditure on research and development of Swiss-based pharmaceutical company Novartis from 2004 to 2019. Novartis AG is one of the world's largest pharma companies. In 2019, Novartis spent approximately 9.4 billion U.S. dollars on research and development.
Novartis AG's expenditure on research and development from 2004 to 2019
(in billion U.S. dollars)
This statistic was assembled from several annual reports.
* With the 2015 Annual Report, values back to 2011 were restated, as a result of a series of transactions during 2015.
** During 2019, eye care division Alcon was spun off and became an own company. Thus, Alcon's expenses are not included.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Novartis. (January 29, 2020). Novartis AG's expenditure on research and development from 2004 to 2019 (in billion U.S. dollars) [Graph]. In Statista. Retrieved February 18, 2020, from https://www.statista.com/statistics/266134/novartis-expenditure-on-research-and-development-since-2004/
Novartis. "Novartis AG's expenditure on research and development from 2004 to 2019 (in billion U.S. dollars)." Chart. January 29, 2020. Statista. Accessed February 18, 2020. https://www.statista.com/statistics/266134/novartis-expenditure-on-research-and-development-since-2004/
Novartis. (2020). Novartis AG's expenditure on research and development from 2004 to 2019 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: February 18, 2020. https://www.statista.com/statistics/266134/novartis-expenditure-on-research-and-development-since-2004/
Novartis. "Novartis Ag's Expenditure on Research and Development from 2004 to 2019 (in Billion U.S. Dollars)." Statista, Statista Inc., 29 Jan 2020, https://www.statista.com/statistics/266134/novartis-expenditure-on-research-and-development-since-2004/
Novartis, Novartis AG's expenditure on research and development from 2004 to 2019 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/266134/novartis-expenditure-on-research-and-development-since-2004/ (last visited February 18, 2020)
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.
